Tag: Ibritumomab tiuxetan

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ibritumomab tiuxetan

Anticipated $-0.31 EPS for Spectrum Pharmaceuticals, Inc. (SPPI) on May, 1

Added to Collection on: 2018-04-12 12:30:00

Tags for this article:

Finance
NASDAQ
Economy of the United States
Biotechnology
Science and Public Policy Institute
Spectrum Pharmaceuticals
Pralatrexate
Ibritumomab tiuxetan

Click the tags to see associated articles and topics

View Article Details
$-0.28 EPS Expected for Spectrum Pharmaceuticals, Inc. (SPPI) on May, 1

Added to Collection on: 2018-04-19 08:42:47

Tags for this article:

NASDAQ
Biotechnology
Science and Public Policy Institute
Spectrum Pharmaceuticals
Industries
Life Sciences
Pralatrexate
Ibritumomab tiuxetan
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Odronextamab Shows Intriguing Antitumor Activity in Relapsed/Refractory B-Cell NHL

Added to Collection on: 2020-12-06 23:37:30

Tags for this article:

Clinical medicine
Medical specialties
Medicine
Non-Hodgkin lymphoma
Gene therapy
Diffuse large B-cell lymphoma
Chimeric antigen receptor T cell
Mantle cell lymphoma
Lymphoma
Cytokine release syndrome
Loncastuximab tesirine
Ibritumomab tiuxetan

Click the tags to see associated articles and topics

View Article Details
Monoclonal antibody therapy Market Insights, Share, Emerging Trends

Added to Collection on: 2021-01-14 04:41:15

Tags for this article:

Medical specialties
Immunology
Clinical medicine
Medicine
Monoclonal antibody
Humanized antibody
Antibody
Ozogamicin
Ibritumomab tiuxetan
Antibody Solutions

Click the tags to see associated articles and topics

View Article Details
BioInvent Phase I/IIa data suggest BI-1206 restores activity of rituximab in relapsed non-Hodgkin's ...

Added to Collection on: 2021-01-28 07:07:30

Tags for this article:

Drugs
Clinical medicine
Non-Hodgkin lymphoma
Orphan drugs
Health care
Mantle cell lymphoma
Cancer immunotherapy
Rituximab
Monoclonal antibodies
Antibody-drug conjugates
David G. Maloney
Ibritumomab tiuxetan
BINV.ST
BioInvent International AB

Click the tags to see associated articles and topics

View Article Details
Armand Reviews Novel Therapeutics in Relapsed/Refractory Follicular Lymphoma

Added to Collection on: 2021-03-02 21:33:45

Tags for this article:

Clinical medicine
Medicine
Breakthrough therapy
Cancer immunotherapy
Immunotherapy
Virotherapy
Health sciences
CD20
ICE
Lymphoma
Ibritumomab tiuxetan
Primary cutaneous diffuse large B-cell lymphoma, leg type
Dana–Farber Cancer Institute

Click the tags to see associated articles and topics

View Article Details
Year in Review: Follicular Lymphoma | MedPage Today

Added to Collection on: 2023-12-01 22:28:34

Tags for this article:

Lymphoma
Non-Hodgkin lymphoma
Orphan drugs
Antineoplastic drugs
Phosphoinositide 3-kinase inhibitor
Targeted therapy
Copanlisib
Diffuse large B-cell lymphoma
Rituximab
Hodgkin lymphoma
Ibritumomab tiuxetan
P110α

Click the tags to see associated articles and topics

View Article Details
Book a Demo